The Centre told the Kerala High Court on Thursday that the 84-day gap between two Covishield doses has been prescribed on account of efficacy, Live Law reported.
The central government stated that the gap was increased based on a recommendation by the National Expert Group on Vaccine Administration for Covid-19 for better protection against the disease.
The Centre made the statement in response to a petition by a company named Kitex Garments Ltd, which sought permission to administer the second Covishield dose to its employees before the completion of 84 days from the first dose.
The Union health ministry on May 13 increased the gap between two doses of Astrazeneca’s Covishield vaccine to 12 weeks to 16 weeks from the earlier gap of six to eight weeks.
On August 25, the Kerala High Court had asked the Centre to state whether the 84-day gap was on account of efficacy or availability of the vaccines.
During the hearing, Daya Sindhu Sreehari, the counsel for the central government, told the court that the time interval was based on a scientific study, and that it was necessary for the vaccine’s effectiveness, the Hindustan Times reported.
Justice PB Suresh Kumar has directed the Centre to file a statement on the matter by August 31.
Kitex Garments, in its petition, has stated that it has already inoculated over 5,000…